Johnson & Johnson - the writing was on the wall...

Updated: Jan 16, 2019

Responsible investors can be forgiven for experiencing more than a little schadenfreude over Johnson & Johnson's tumble on US markets before Christmas.

The US healthcare giant saw more than $54 billion wiped from its sharemarket value in a single day following reports that it knew batches of its iconic baby powder were contaminated with asbestos, a known carcinogen. And since then the rout has continued.

But for responsible investors, those that consider a company's environmental, social and governance (ESG) performance alongside traditional financial measures such as revenue growth, profit, loss and balance sheet strength, the reports contained nothing new. Read more here:

36 views0 comments
  • Facebook Social Icon
  • LinkedIn Social Icon


This information is general information only and does not take account of your individual investment objectives or financial situation.
Pathfinder Asset Management encourages all investors to seek independent financial advice prior to making investment decisions.